Cardax Inc (CDXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cardax Inc (CDXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH137686D
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug products. Its astaxanthin is a small molecule compound found in marine organisms that includes microalgae, salmon and trout, and crustaceans, among others. Cardax's product reduces the inflammation of many anti-inflammatory products. The company's products address the market segments such as metabolic syndrome, osteoarthritis, cognitive decline, hepatic disease, triglycerides, diabetes, atherosclerosis and thrombosis, among others. It also provides scientific data to physicians and patient groups. Cardax is headquartered in Honolulu, Hawaii, the US.

Cardax Inc (CDXI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note : Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cardax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Cardax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Cardax Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Cardax Pharma Raises USD 2 Million In Venture Financing 11

Cardax Pharma Raises USD 0.8 Million In Venture Financing 12

Partnerships 13

Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13

Merger 14

Koffee Korner Merges with Cardax Pharma 14

Licensing Agreements 15

Biomiga Diagnostics Enters into Licensing Agreement with Cardax 15

Equity Offering 16

Cardax Raises USD1.2 Million in Public Offering of Shares 16

Cardax Pharma Raises USD0.05 Million in Private Placement of Shares 17

Cardax Raises Funds in Private Placement of Shares 18

Cardax Raises USD0.5 Million in Financing 19

Cardax Raises Additional USD0.5 Million in Financing 20

Cardax Pharma Raises USD4 Million in Private Placement 21

Cardax Pharma Raises USD2 Million in Private Placement 22

Cardax Pharma Raises USD5 Million in Private Placement 23

Debt Offering 24

Cardax Pharma Raises USD2 Million in Public Offering of 10% Notes 24

Cardax Inc-Key Competitors 25

Cardax Inc-Key Employees 26

Cardax Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Aug 13, 2018: Cardax reports Q2 2018 results 28

Mar 27, 2018: Cardax Reports 2017 Results 29

Nov 14, 2017: Cardax Reports Q3 2017 Results 30

Aug 11, 2017: Cardax Reports Q2 2017 Results 31

May 15, 2017: Cardax Q1 2017 Revenues Triple vs. Prior Two Quarters Combined 32

Corporate Communications 33

Jun 01, 2018: Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors 33

Sep 07, 2017: Cardax Promotes David M. Watumull to COO; Partially Restores Compensation Company-Wide 34

Jan 10, 2017: Cardax Appoints Global Healthcare Executive as Independent Director 35

Product News 36

Sep 19, 2017: Cardax Welcomes Cardiovascular Research Breakthrough 36

Jun 13, 2018: Cardax Engages Industry Veteran Fred Sancilio, Ph.D., to Launch Orphan Drug Development Program 37

03/28/2017: Cardax Astaxanthin Compound CDX-085 Stimulates Anti-Aging Gene in Mice 38

Jan 25, 2017: Cardax Announces Launch of ZanthoSyn in Hawaii GNC Stores 39

Other Significant Developments 40

Feb 17, 2018: Cardax's ZanthoSyn is No. 1 Seller at GNC Hawaii Stores 40

Feb 17, 2018: Cardax Inks Deal to Distribute ZanthoSyn in China 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42

List of Figures

Cardax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cardax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

List of Tables

Cardax Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Cardax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Cardax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Cardax Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Cardax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Cardax Pharma Raises USD 2 Million In Venture Financing 11

Cardax Pharma Raises USD 0.8 Million In Venture Financing 12

Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 13

Koffee Korner Merges with Cardax Pharma 14

Biomiga Diagnostics Enters into Licensing Agreement with Cardax 15

Cardax Raises USD1.2 Million in Public Offering of Shares 16

Cardax Pharma Raises USD0.05 Million in Private Placement of Shares 17

Cardax Raises Funds in Private Placement of Shares 18

Cardax Raises USD0.5 Million in Financing 19

Cardax Raises Additional USD0.5 Million in Financing 20

Cardax Pharma Raises USD4 Million in Private Placement 21

Cardax Pharma Raises USD2 Million in Private Placement 22

Cardax Pharma Raises USD5 Million in Private Placement 23

Cardax Pharma Raises USD2 Million in Public Offering of 10% Notes 24

Cardax Inc, Key Competitors 25

Cardax Inc, Key Employees 26

Cardax Inc, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Cardax Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 17970
Site License
USD 500 INR 35940
Corporate User License
USD 750 INR 53910

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com